Latest News

Keep up to date with the latest news from our team at the Kolling Institute of Medical Research. By subscribing to our newsletter, you’ll discover more about our dedicated teams and their latest findings. You’ll have access to information about upcoming events and you’ll hear about opportunities to support our research.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Important national COVID-19 study

Important national COVID-19 study

For many people with heart disease there’s an increased level of anxiety around the implications of COVID-19, but it’s hoped a new study led by Royal North Shore Hospital will guide future treatment and improve health outcomes. Head of cardiology Professor Ravinay Bhindi has launched the AUS-COVID study, which will involve more than 800 patients in over 20 hospitals across Australia. The..... Read more

Category: Research Excellence

Multiple medications cause frailty, but this can be reversed

Multiple medications cause frailty, but this can be reversed

A world-first study by a team from the Kolling Institute may inform the future use of multiple medications by older people, minimising adverse impacts including frailty. The longitudinal research is the first preclinical study to demonstrate that multiple medications can impair function in old age, and that stopping some can reduce harm. Research lead, Professor Sarah Hilmer said until ..... Read more

Category: Research Excellence

Celebrating 100 years of research excellence

Celebrating 100 years of research excellence

2020 is an important year for the Kolling Institute as it marks the 100 year anniversary of the research organisation. As the longest-running medical research institute in New South Wales, the Kolling has a very rich history. Originally named the Institute of Pathological Research of NSW, the organisation was established in a cottage within the grounds of Royal North Shore Hospital in 1..... Read more

Category: Research Excellence

Valuable biobanking resource improving health outcomes and strengthening research

Valuable biobanking resource improving health outcomes and strengthening research

For nearly three decades, the Kolling Institute Tumour Bank has been quietly and consistently building a large state resource. It was established in 1992 with a small number of endocrine tumours. Today, it also has breast, colorectal and gynaecological tumour collections, as well as neurological and gastrointestinal samples. The significance of the resource has been recognised in recent..... Read more

Category: Research Excellence

New funding to help reduce Australia’s bowel cancer rates

New funding to help reduce Australia’s bowel cancer rates

Professor Mark Molloy’s ground-breaking bowel cancer research has received a boost, with the Cancer Council NSW awarding the Kolling Institute researcher a three-year $450,000 grant. Professor Molloy has welcomed the funding, saying bowel cancer claims more lives each year than breast, prostate or skin cancer. “It is now Australia’s second biggest cancer killer, with more than 300 Austra..... Read more

Category: Funding support

Newsletter

Newsletter

Read more

Category: Newsletters

International focus on our ovarian cancer research

International focus on our ovarian cancer research

In an exciting breakthrough, researchers from the Kolling Institute’s Bill Walsh Lab have identified new genes involved in the spread of ovarian cancer. Tragically, it is the deadliest female cancer, claiming more than 900 lives in Australia each year. Most women are diagnosed relatively late, when the cancer has spread, significantly reducing their chances of survival. The ovarian cance..... Read more

Category: Research Excellence

Home grown ideas place physio in patients' hands

Home grown ideas place physio in patients' hands

New research is testing a new way to meet the rapidly growing demand for physiotherapy in our public hospitals. A clinical trial at four hospitals, including Hornsby and Royal North Shore, is studying whether some patients can successfully undertake physiotherapy exercises at home and still experience the same benefit provided by attending a hospital clinic. “Demand for physio is increa..... Read more

Category: New Treatment

Common medication may lower risk of “heartbreak”

Common medication may lower risk of “heartbreak”

RNSH cardiologist Professor Geoffrey Tofler has led a world-first study which found that common medications can reduce the risk of heart attack in those grieving a loved one. Professor Tofler said while most people gradually adjust to the loss of a loved one, there is an increase in heart attacks and death among bereaved people, particularly those grieving a spouse or child. “This risk ..... Read more

Category: Research Excellence

Research spotlight on specialist NICU team

Research spotlight on specialist NICU team

Celebrity couple Hayden James and Jennifer Luby shared their emotional journey following the premature birth of their son during the inaugural Women and Babies Research team seminar at the Kolling. Hayden, an award winning Australian musician and DJ, and his wife Jennifer, a Sydney-based artist, spent 87 days in the Neonatal Intensive Care Unit at RNSH last year. Their son James was bor..... Read more

Category: Research Excellence